These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 30024783)
1. The economic costs of jail-based methadone maintenance treatment. Horn BP; Li X; Mamun S; McCrady B; French MT Am J Drug Alcohol Abuse; 2018; 44(6):611-618. PubMed ID: 30024783 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of a large jail-based methadone maintenance treatment continuation program in New Mexico. Horn BP; Li X; McCrady B; Guerin P; French MT J Subst Abuse Treat; 2020 Aug; 115():108042. PubMed ID: 32600623 [TBL] [Abstract][Full Text] [Related]
3. Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail. Zarkin GA; Orme S; Dunlap LJ; Kelly SM; Mitchell SG; O'Grady KE; Schwartz RP Drug Alcohol Depend; 2020 Dec; 217():108292. PubMed ID: 32992151 [TBL] [Abstract][Full Text] [Related]
4. Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial. Schwartz RP; Kelly SM; Mitchell SG; Dunlap L; Zarkin GA; Sharma A; O'Grady KE; Jaffe JH Contemp Clin Trials; 2016 Jul; 49():21-8. PubMed ID: 27282117 [TBL] [Abstract][Full Text] [Related]
5. Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal. Moore KE; Oberleitner L; Smith KMZ; Maurer K; McKee SA J Addict Med; 2018; 12(2):156-162. PubMed ID: 29341974 [TBL] [Abstract][Full Text] [Related]
6. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study. Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467 [TBL] [Abstract][Full Text] [Related]
7. Cost of provision of opioid substitution therapy provision in Tijuana, Mexico. Burgos JL; Cepeda JA; Kahn JG; Mittal ML; Meza E; Lazos RRP; Vargas PC; Vickerman P; Strathdee SA; Martin NK Harm Reduct J; 2018 May; 15(1):28. PubMed ID: 29792191 [TBL] [Abstract][Full Text] [Related]
8. Dynamics in the costs of criminality among opioid dependent individuals. Krebs E; Kerr T; Montaner J; Wood E; Nosyk B Drug Alcohol Depend; 2014 Nov; 144():193-200. PubMed ID: 25282307 [TBL] [Abstract][Full Text] [Related]
9. The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings. Chandler RK; Finger MS; Farabee D; Schwartz RP; Condon T; Dunlap LJ; Zarkin GA; McCollister K; McDonald RD; Laska E; Bennett D; Kelly SM; Hillhouse M; Mitchell SG; O'Grady KE; Lee JD Contemp Clin Trials; 2016 May; 48():166-72. PubMed ID: 27180088 [TBL] [Abstract][Full Text] [Related]
10. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Connock M; Juarez-Garcia A; Jowett S; Frew E; Liu Z; Taylor RJ; Fry-Smith A; Day E; Lintzeris N; Roberts T; Burls A; Taylor RS Health Technol Assess; 2007 Mar; 11(9):1-171, iii-iv. PubMed ID: 17313907 [TBL] [Abstract][Full Text] [Related]
11. Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis. King JB; Sainski-Nguyen AM; Bellows BK J Pain Palliat Care Pharmacother; 2016; 30(1):55-65. PubMed ID: 27007583 [TBL] [Abstract][Full Text] [Related]
12. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail. Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100 [TBL] [Abstract][Full Text] [Related]
13. Community-Based Methadone Maintenance in a Large Detention Center is Associated with Decreases in Inmate Recidivism. Westerberg VS; McCrady BS; Owens M; Guerin P J Subst Abuse Treat; 2016 Nov; 70():1-6. PubMed ID: 27692182 [TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness and budget impact of Vietnam's methadone maintenance treatment programme in HIV prevention and treatment among injection drug users. Tran BX; Ohinmaa A; Duong AT; Nguyen LT; Vu PX; Mills S; Houston S; Jacobs P Glob Public Health; 2012; 7(10):1080-94. PubMed ID: 23106230 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial. Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873 [TBL] [Abstract][Full Text] [Related]
16. Economic vulnerability of methadone maintenance patients: Implications for policies on co-payment services. Tran BX; Phan HT; Nguyen LH; Nguyen CT; Nguyen AT; Le TN; Latkin CA Int J Drug Policy; 2016 May; 31():131-7. PubMed ID: 26922633 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of center-based compulsory rehabilitation compared to community-based voluntary methadone maintenance treatment in Hai Phong City, Vietnam. Vuong T; Shanahan M; Nguyen N; Le G; Ali R; Pham K; Vuong TTA; Dinh T; Ritter A Drug Alcohol Depend; 2016 Nov; 168():147-155. PubMed ID: 27664552 [TBL] [Abstract][Full Text] [Related]
19. Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment. Reimer J; Vogelmann T; Trümper D; Scherbaum N Subst Abuse Treat Prev Policy; 2019 Dec; 14(1):57. PubMed ID: 31842942 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction. Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]